You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AAV.7m8-aflibercept

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetic Macular Edema, Diabetic Retinopathy Trial in Puerto Rico, United States (6E11 vg/eye of ADVM-022, 2E11 vg/eye of

Active, not recruiting
  • Diabetic Macular Edema
  • Diabetic Retinopathy
  • 6E11 vg/eye of ADVM-022
  • +2 more
  • Phoenix, Arizona
  • +13 more
Jan 10, 2022

Wet Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration Trial in United States (ADVM-022)

Active, not recruiting
  • Wet Age-related Macular Degeneration
  • Neovascular Age-related Macular Degeneration
  • ADVM-022
  • Bakersfield, California
  • +10 more
Mar 21, 2022

Neovascular Age-related Macular Degeneration Trial in United States (ADVM-022)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • ADVM-022
  • Phoenix, Arizona
  • +4 more
Sep 8, 2022

Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)

Enrolling by invitation
  • Diabetic Macular Edema
  • Diabetic Retinopathy
  • ADVM-022
  • Beverly Hills, California
  • +6 more
Nov 4, 2022

Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]

Enrolling by invitation
  • Wet Age-related Macular Degeneration
  • Neovascular Age-related Macular Degeneration
  • ADVM-022
  • Bakersfield, California
  • +8 more
Dec 23, 2021

Age-Related Macular Degeneration Trial in Toronto (NG101 AAV gene therapy)

Not yet recruiting
  • Age-Related Macular Degeneration
  • NG101 AAV gene therapy
  • Toronto, Ontario, Canada
    Vitreous Retina Macula Specialists of Toronto
Aug 2, 2023

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial in Canada,

Active, not recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +20 more
  • Pembrolizumab
  • Ziv-Aflibercept
  • Tampa, Florida
  • +8 more
Jan 3, 2023

Achromatopsia Trial in Ann Arbor, London (either AAV - CNGB3 or AAV - CNGA3)

Active, not recruiting
  • Achromatopsia
  • either AAV - CNGB3 or AAV - CNGA3
  • Ann Arbor, Michigan
  • +1 more
Jan 13, 2022

Achromatopsia Trial in Ann Arbor, London (adeno-associated virus vector AAV- CNGA3)

Completed
Has Results
  • Achromatopsia
  • adeno-associated virus vector AAV- CNGA3
  • Ann Arbor, Michigan
  • +1 more
Feb 10, 2022

OTC Deficiency Trial in Worldwide (genetic, other, drug)

Recruiting
  • OTC Deficiency
  • DTX301
  • +4 more
  • Aurora, Colorado
  • +19 more
Jul 29, 2022

The Impact of Opioid and Cannabis Exposure on Fetal Growth

Recruiting
  • Pregnancy Related
  • +3 more
    • Hamilton, Ontario, Canada
    • +4 more
    Jun 2, 2023

    Infection Trial in Canada (Fecal Microbiota Transplantation (FMT))

    Suspended
    • Infection
    • Fecal Microbiota Transplantation (FMT)
    • Brampton, Ontario, Canada
    • +12 more
    Nov 1, 2022

    COVID-19 Trial in Canada (Artesunate, Imatinib, Infliximab)

    Recruiting
    • COVID-19
    • Calgary, Alberta, Canada
    • +56 more
    Jan 12, 2023

    Hemangioma, Kaposiform Hemangioendothelioma Trial in Shanghai (Sirolimus(0.8mg/m2), Sirolimus(0.7mg/m2))

    Completed
    • Hemangioma
    • Kaposiform Hemangioendothelioma
    • Shanghai, China
      Children's Hospital of Fudan University
    Jan 27, 2023

    Adults With Severe Eosinophilic Asthma on Benralizumab.

    Active, not recruiting
    • Severe Eosinophilic Asthma
    • Survey Administration
    • Calgary, Alberta, Canada
    • +19 more
    Dec 1, 2022

    Bipolar Disorder Trial in Canada (Cannabidiol, Placebo)

    Not yet recruiting
    • Bipolar Disorder
    • Calgary, Alberta, Canada
    • +7 more
    May 18, 2023

    Choroideremia, X-Linked Retinitis Pigmentosa Trial in Worldwide (BIIB111, BIIB112)

    Enrolling by invitation
    • Choroideremia
    • X-Linked Retinitis Pigmentosa
    • BIIB111
    • BIIB112
    • Los Angeles, California
    • +22 more
    Apr 20, 2022

    Oral Upadacitinib Tablets to Assess Change in Disease Symptoms

    Recruiting
    • Rheumatoid Arthritis (RA)
      • Edmonton, Alberta, Canada
      • +38 more
      Jan 17, 2023

      Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8

      Active, not recruiting
      • Anatomic Stage IIB Breast Cancer AJCC v8
      • +19 more
      • Gilbert, Arizona
      • +4 more
      Dec 6, 2022

      Osteoarthritis Trial in Canada (ATB-346 low dose, Placebo, ATB-346 mid-dose)

      Completed
      • Osteoarthritis
      • ATB-346 low dose
      • +3 more
      • Mission, British Columbia, Canada
      • +34 more
      Jul 20, 2022

      Brodalumab in Plaque Psoriasis to Understand Impact on Quality

      Recruiting
      • Psoriasis
      • Brodalumab
      • Matched cohort
      • Calgary, Alberta, Canada
      • +33 more
      Oct 8, 2022

      Cancer, Tumour, Surgery Trial in Canada, United States (Tranexamic acid (TXA), Normal saline)

      Active, not recruiting
      • Cancer
      • +2 more
      • Tranexamic acid (TXA)
      • Normal saline
      • Rochester, Minnesota
      • +10 more
      Oct 25, 2022

      EBV-Related Hodgkin Lymphoma, Lymphoproliferative Disorders, EBV Related Non-Hodgkin's Lymphoma Trial in Houston (Dose Level 1A:

      Not yet recruiting
      • EBV-Related Hodgkin Lymphoma
      • +2 more
      • Dose Level 1A: 2 x 10^7 cells/m2
      • +4 more
      • Houston, Texas
      • +1 more
      Feb 7, 2022

      Oropharyngeal Cancer Trial in Canada (Radiation, Cisplatin)

      Active, not recruiting
      • Oropharyngeal Cancer
      • Prince George, British Columbia, Canada
      • +13 more
      Dec 12, 2022

      Breast Cancer Trial in Canada (CFI-402257, Paclitaxel)

      Active, not recruiting
      • Breast Cancer
      • Vancouver, British Columbia, Canada
      • +3 more
      Jan 30, 2023